Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol

Detalhes bibliográficos
Autor(a) principal: Megda, Tábata Torres
Data de Publicação: 2022
Outros Autores: Sousa, Felipe Gaia de, Miranda, Fernanda Guimarães, Barreto, Maira Souza Oliveira, Mattoso, Cláudio Roberto Scabelo, Beier, Suzane Lilian
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/34902
Resumo: This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study.
id UNIFEI_f0b0d6c280a540258fe750af456c08d9
oai_identifier_str oai:ojs.pkp.sfu.ca:article/34902
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanolEvaluación ecocardiográfica de felinos sedados con dexmedetomidina o xilacina asociada a butorfanolAvaliação ecocardiográfica de felinos sedados com dexmedetomidina ou xilazina associada com butorfanolAdrenergic alpha-2 receptor agonistsCardiac OutputCatsEchocardiography.Agonistas de receptores adrenérgicos alfa 2Gasto cardíacoGatosEcocardiografía.Agonistas de receptores adrenérgicos alfa 2Débito cardíacoGatosEcocardiografia.This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study.Este estudio de cohorte prospectivo tuvo como objetivo evaluar mediante ecocardiograma los efectos cardiovasculares de los agentes α2 asociados con butorfanol en gatos. Un grupo de 18 gatos mestizos con un peso medio de 3,65 + 0,7 kg, con una edad aproximada de 6 meses. Los gatos fueron asignados en tres grupos, XB (grupo xilacina/butorfanol): sedación con 0,5 mg/kg de xilacina y 0,5 mg/kg de butorfanol IM; DB (grupo Dexmedetomidina/butorfanol): sedación con 20 µg/kg de dexmedetomidina y 0,5 mg/kg de butorfanol IM; C: grupo control que recibió solución salina en volumen aproximado a los utilizados en los otros grupos, IM. Variables ecocardiográficas como fracción de eyección (método de Simpson y modo M) y fracción de acortamiento del ventrículo izquierdo (modo M), volumen de eyección, volumen telesistólico y gasto cardíaco (Teichholz), velocidades de onda Doppler tisular E' y A' e índice cardíaco fueron evaluados. Hubo una reducción en las variables ecocardiográficas en comparación con el grupo control, siendo estadísticamente significativas para frecuencia cardíaca, fracción de eyección (% por Simpson), fracción de acortamiento (% en modo M) y volumen telesistólico en los grupos XB y DB, y velocidad de onda Doppler tisular E' y A' (m/s), cociente E'/A', gasto cardíaco e índice cardíaco solo en el grupo XB. Cuando se compararon entre sí, XB y DB diferían significativamente en la velocidad de onda Doppler tisular E' y A' (m/s) y en la relación E'/A'. La xilacina fue más deletérea que la dexmedetomidina en la mayoría de las variables evaluadas, lo que provocó una reducción significativa del gasto cardíaco y del índice cardíaco a las dosis utilizadas en este estudio.Este estudo de coorte prospectivo teve como objetivo avaliar por ecocardiograma os efeitos cardiovasculares de agentes α2 associados ao butorfanol em gatos. Um grupo de 18 gatos sem raça definida com peso médio de 3,65 + 0,7 kg, com idade aproximada de 6 meses. Os gatos foram divididos em três grupos, sedação XB (grupo xilazina/butorfanol) com 0,5 mg/kg de xilazina e 0,5 mg/kg de butorfanol IM; DB (grupo Dexmedetomidina/butorfanol): sedação com 20 µg/kg de dexmedetomidina e 0,5 mg/kg de butorfanol IM; C: grupo controle que recebeu solução salina em volume próximo aos utilizados nos demais grupos, IM. Variáveis ecocardiográficas como fração de ejeção (método de Simpson e modo M) e fração de encurtamento do ventrículo esquerdo (modo M), volume de ejeção, volume sistólico e débito cardíaco (Teichholz), velocidades das ondas E' e A' do Doppler tecidual e índice cardíaco foram avaliados. Houve redução das variáveis ecocardiográficas em relação ao grupo controle, sendo estatisticamente significante para frequência cardíaca, fração de ejeção (% por Simpson), fração de encurtamento (% em modo M) e volume sistólico final nos grupos XB e DB e tecido Velocidade das ondas E' e A' Doppler (m/s), relação E'/A', débito cardíaco e índice cardíaco apenas no grupo XB. Quando comparados entre si, XB e DB diferiram significativamente na velocidade de onda E' e A' do Doppler tecidual (m/s) e na relação E'/A'. A xilazina foi mais deletéria que a dexmedetomidina na maioria das variáveis avaliadas, levando a uma redução significativa do débito cardíaco e do índice cardíaco nas doses utilizadas neste estudo.Research, Society and Development2022-09-24info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3490210.33448/rsd-v11i12.34902Research, Society and Development; Vol. 11 No. 12; e559111234902Research, Society and Development; Vol. 11 Núm. 12; e559111234902Research, Society and Development; v. 11 n. 12; e5591112349022525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/34902/29380Copyright (c) 2022 Tábata Torres Megda; Felipe Gaia de Sousa; Fernanda Guimarães Miranda; Maira Souza Oliveira Barreto; Cláudio Roberto Scabelo Mattoso; Suzane Lilian Beierhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessMegda, Tábata Torres Sousa, Felipe Gaia de Miranda, Fernanda Guimarães Barreto, Maira Souza Oliveira Mattoso, Cláudio Roberto Scabelo Beier, Suzane Lilian 2022-09-26T11:56:08Zoai:ojs.pkp.sfu.ca:article/34902Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:01.082619Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
Evaluación ecocardiográfica de felinos sedados con dexmedetomidina o xilacina asociada a butorfanol
Avaliação ecocardiográfica de felinos sedados com dexmedetomidina ou xilazina associada com butorfanol
title Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
spellingShingle Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
Megda, Tábata Torres
Adrenergic alpha-2 receptor agonists
Cardiac Output
Cats
Echocardiography.
Agonistas de receptores adrenérgicos alfa 2
Gasto cardíaco
Gatos
Ecocardiografía.
Agonistas de receptores adrenérgicos alfa 2
Débito cardíaco
Gatos
Ecocardiografia.
title_short Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
title_full Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
title_fullStr Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
title_full_unstemmed Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
title_sort Echocardiographic assessment of felines sedated with dexmedetomidine or xylazine associated with butorphanol
author Megda, Tábata Torres
author_facet Megda, Tábata Torres
Sousa, Felipe Gaia de
Miranda, Fernanda Guimarães
Barreto, Maira Souza Oliveira
Mattoso, Cláudio Roberto Scabelo
Beier, Suzane Lilian
author_role author
author2 Sousa, Felipe Gaia de
Miranda, Fernanda Guimarães
Barreto, Maira Souza Oliveira
Mattoso, Cláudio Roberto Scabelo
Beier, Suzane Lilian
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Megda, Tábata Torres
Sousa, Felipe Gaia de
Miranda, Fernanda Guimarães
Barreto, Maira Souza Oliveira
Mattoso, Cláudio Roberto Scabelo
Beier, Suzane Lilian
dc.subject.por.fl_str_mv Adrenergic alpha-2 receptor agonists
Cardiac Output
Cats
Echocardiography.
Agonistas de receptores adrenérgicos alfa 2
Gasto cardíaco
Gatos
Ecocardiografía.
Agonistas de receptores adrenérgicos alfa 2
Débito cardíaco
Gatos
Ecocardiografia.
topic Adrenergic alpha-2 receptor agonists
Cardiac Output
Cats
Echocardiography.
Agonistas de receptores adrenérgicos alfa 2
Gasto cardíaco
Gatos
Ecocardiografía.
Agonistas de receptores adrenérgicos alfa 2
Débito cardíaco
Gatos
Ecocardiografia.
description This prospective cohort study aimed to evaluate by echocardiogram the cardiovascular effects of α2 agents associated with butorphanol in cats. A group of 18 mixed-breed cats with a mean weight of 3.65 + 0.7 kg, with an approximate age of 6 months. The cats were assigned in three groups, XB (Xylazine/butorphanol group) sedation with 0.5 mg/kg of xylazine and 0.5 mg/kg of butorphanol IM; DB (Dexmedetomidine/butorphanol group): sedation with 20 µg/kg of dexmedetomidine and 0.5 mg/kg of butorphanol IM; C: control group which received saline solution in volume approximated to those used in the other groups, IM. Echocardiographic variables as ejection fraction (Simpson's method and M-mode) and left ventricular shortening fraction (M-mode), ejection volume, end-systolic volume and cardiac output (Teichholz), tissue Doppler E' and A' wave velocities and cardiac index were evaluated. There was a reduction in echocardiographic variables compared with the control group, being statistically significant for heart rate, ejection fraction (% by Simpson), shortening fraction (% in M-mode) and end-systolic volume in XB and DB groups, and tissue Doppler E' and A' wave velocity (m/s), E'/A' ratio, cardiac output and cardiac index only in XB group. When compared to each other, XB and DB differed significantly in the tissue Doppler E' and A' wave velocity (m/s), and E'/A' ratio. Xylazine was more deleterious than dexmedetomidine in most of the variables evaluated, leading to a significant reduction in cardiac output and cardiac index at the doses used in this study.
publishDate 2022
dc.date.none.fl_str_mv 2022-09-24
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/34902
10.33448/rsd-v11i12.34902
url https://rsdjournal.org/index.php/rsd/article/view/34902
identifier_str_mv 10.33448/rsd-v11i12.34902
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/34902/29380
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 12; e559111234902
Research, Society and Development; Vol. 11 Núm. 12; e559111234902
Research, Society and Development; v. 11 n. 12; e559111234902
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052723788513280